138 related articles for article (PubMed ID: 15218975)
1. Tetraploid acute promyelocytic leukemia with double PML/RARA gene rearrangements successfully treated with all-trans retinoic acid.
Kuyama J; Tsumori Y; Aoyama K; Kosugi S; Take H; Matsuyama T
Int J Hematol; 2004 May; 79(4):405-6. PubMed ID: 15218975
[No Abstract] [Full Text] [Related]
2. A novel HNRNPC-RARA fusion in acute promyelocytic leukaemia lacking PML-RARA rearrangement, sensitive to venetoclax-based therapy.
Liu M; Zhao X; Pan W; Qian Z; Du M; Wang LM; Huang H; Xiao H
Br J Haematol; 2021 Oct; 195(2):e123-e128. PubMed ID: 34254314
[No Abstract] [Full Text] [Related]
3. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia.
Lee GY; Christina S; Tien SL; Ghafar AB; Hwang W; Lim LC; Lim TH
Cancer Genet Cytogenet; 2005 Jun; 159(2):129-36. PubMed ID: 15899384
[TBL] [Abstract][Full Text] [Related]
4. Acute promyelocytic leukemia with apparently normal karyotype: molecular findings and response to all-trans retinoic acid.
Kohno A; Tsuzuki S; Kasai M; Miyamura K; Emi N; Tanimoto M; Saito H
Leuk Lymphoma; 2001 Jun; 42(1-2):151-61. PubMed ID: 11699203
[TBL] [Abstract][Full Text] [Related]
5. [Retinoic acid receptor alpha gene in t (15; 17) APL].
Takashima T; Misawa S
Nihon Rinsho; 1992 Jun; 50(6):1363-8. PubMed ID: 1325570
[TBL] [Abstract][Full Text] [Related]
6. Tetraploidy acute promyelocytic leuemia with double t(15;17)/PML-RARA, a case report with review of literature.
Dalia SM; Horna P; Zhang L
Int J Clin Exp Pathol; 2014; 7(8):5363-8. PubMed ID: 25197424
[TBL] [Abstract][Full Text] [Related]
7. [Effects of all-trans retinoic acid and arsenic trioxide on tissue factor expression of acute promyelocytic leukemia cells].
Guo W; Wang H; Zhao W
Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):327-31. PubMed ID: 11798779
[TBL] [Abstract][Full Text] [Related]
8. All-trans-retinoic acid in acute promyelocytic leukemia.
Sanz MA; Martín G; Díaz-Mediavilla J
N Engl J Med; 1998 Feb; 338(6):393-4. PubMed ID: 9454087
[No Abstract] [Full Text] [Related]
9. Do RARA/PML fusion gene deletions confer resistance to ATRA-based therapy in patients with acute promyelocytic leukemia?
Subramaniyam S; Nandula SV; Nichols G; Weiner M; Satwani P; Alobeid B; Bhagat G; Murty VV
Leukemia; 2006 Dec; 20(12):2193-5. PubMed ID: 17008891
[No Abstract] [Full Text] [Related]
10. In vitro response to all-trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes.
Mozziconacci MJ; Liberatore C; Brunel V; Grignani F; Arnoulet C; Ferrucci PF; Fernandez F; Sainty D; Pelicci PG; Birg F; Lafage-Pochitaloff M
Genes Chromosomes Cancer; 1998 Jul; 22(3):241-50. PubMed ID: 9624536
[TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukemia with isochromosome 17q and cryptic PML-RARA successfully treated with all-trans retinoic acid and arsenic trioxide.
Shepshelovich D; Oniashvili N; Parnes D; Klein A; Muchtar E; Yeshaya J; Aviram A; Rabizadeh E; Raanani P
Cancer Genet; 2015 Nov; 208(11):575-9. PubMed ID: 26471811
[TBL] [Abstract][Full Text] [Related]
12. All-trans retinoic acid and arsenic trioxide resistance of acute promyelocytic leukemia with the variant STAT5B-RARA fusion gene.
Strehl S; König M; Boztug H; Cooper BW; Suzukawa K; Zhang SJ; Chen HY; Attarbaschi A; Dworzak MN
Leukemia; 2013 Jul; 27(7):1606-10. PubMed ID: 23271512
[No Abstract] [Full Text] [Related]
13. Molecular follow-up of patients with promyelocytic leukaemia treated with all-trans retinoic acid.
Ruiz-Argüelles GJ; Garcés-Eisele J; Ruiz-Argüelles A
Clin Lab Haematol; 1998 Jun; 20(3):173-6. PubMed ID: 9681233
[TBL] [Abstract][Full Text] [Related]
14. Identification of PML/RARalpha rearrangements in suspected acute promyelocytic leukemia using fluorescence in situ hybridization of bone marrow smears: a comparison with cytogenetics and RT-PCR in MRC ATRA trial patients. MRC Adult Leukaemia Working Party.
Iqbal S; Grimwade D; Chase A; Goldstone A; Burnett A; Goldman JM; Swirsky D
Leukemia; 2000 May; 14(5):950-3. PubMed ID: 10803535
[No Abstract] [Full Text] [Related]
15. [All-trans retinoic acid therapy in acute promyelocytic leukemia--current status and prospect].
Kitamura K; Takeshita A; Ono R; Naoe T
Rinsho Ketsueki; 1996 Sep; 37(9):760-5. PubMed ID: 8914458
[No Abstract] [Full Text] [Related]
16. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
[TBL] [Abstract][Full Text] [Related]
17. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway.
Yoshida H; Kitamura K; Tanaka K; Omura S; Miyazaki T; Hachiya T; Ohno R; Naoe T
Cancer Res; 1996 Jul; 56(13):2945-8. PubMed ID: 8674046
[TBL] [Abstract][Full Text] [Related]
18. PML/RAR alpha(+) hypergranular acute promyelocytic leukemia (M3) developing into an M3 acute myelocytic leukemia without PML/RAR alpha.
Ruiz-Argüelles GJ; Ruiz-Delgado GJ; Reyes-Núñez V
Acta Haematol; 2000; 104(2-3):124-7. PubMed ID: 11154988
[TBL] [Abstract][Full Text] [Related]
19. The short isoform of the long-type PML-RARA fusion gene in acute promyelocytic leukaemia lacks sensitivity to all-trans-retinoic acid.
Tan Y; Bian S; Xu Z; Chen X; Qi X; Ren F; Li L; Guo H; Xu A; Zhang L; Wang H
Br J Haematol; 2013 Jul; 162(1):93-7. PubMed ID: 23627671
[TBL] [Abstract][Full Text] [Related]
20. Identification of the novel deletion-type PML-RARA mutation associated with the retinoic acid resistance in acute promyelocytic leukemia.
Hattori H; Ishikawa Y; Kawashima N; Akashi A; Yamaguchi Y; Harada Y; Hirano D; Adachi Y; Miyao K; Ushijima Y; Terakura S; Nishida T; Matsushita T; Kiyoi H
PLoS One; 2018; 13(10):e0204850. PubMed ID: 30289902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
